| RVA Receipt of Interim Funding Commitment and Leadership Changes |
| 25/03/19 | PRICE SENSITIVE | | Share |
|
| RVA REVA Continues Suspension of Trading |
| 13/03/19 | | | Share |
|
| RVA S&P DJI Announces March 2019 Quarterly Rebalance |
| 08/03/19 | PRICE SENSITIVE | | Share |
|
| RVA Extension of Voluntary Suspension |
| 06/03/19 | | | Share |
|
| RVA Extension to Voluntary Suspension |
| 25/02/19 | | | Share |
|
| RVA Response to ASX Appendix 4C Query Letter |
| 22/02/19 | PRICE SENSITIVE | | Share |
|
| RVA Voluntary Suspension |
| 20/02/19 | PRICE SENSITIVE | | Share |
|
| RVA Trading Halt |
| 18/02/19 | PRICE SENSITIVE | | Share |
|
| RVA REVA Announces Reduction in Force |
| 05/02/19 | PRICE SENSITIVE | | Share |
|
| RVA Appendix 4C - quarterly |
| 31/01/19 | PRICE SENSITIVE | | Share |
|
| RVA REVA expands Geographic Footprint to Seven New Countries |
| 07/01/19 | PRICE SENSITIVE | | Share |
|
| RVA CFO and Company Secretary Appointment/Resignation |
| 04/01/19 | | | Share |
|
| RVA First Fantom Encore Bioresorbable Scaffold Implant in Italy |
| 04/12/18 | | | Share |
|
| RVA Appendix 3B |
| 28/11/18 | | | Share |
|
| RVA REVA Medical to Present at Canaccord Genuity Forum |
| 15/11/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA Announces Departure of Richard Kimes, SVP of Operations |
| 08/11/18 | | | Share |
|
| RVA Q3 2018 Quarterly Report on Form 10-Q |
| 06/11/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA Medical Reports Third Quarter 2018 Financial Results |
| 06/11/18 | PRICE SENSITIVE | | Share |
|
| RVA Commercial Launch of Fantom Encore Bioresorbable Scaffold |
| 01/11/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Hold Third Quarter 2018 Financial Results Call |
| 30/10/18 | | | Share |
|
| RVA Appendix 4C - quarterly |
| 30/10/18 | PRICE SENSITIVE | | Share |
|
| RVA Appendix 3B |
| 08/10/18 | | | Share |
|
| RVA Appendix 3B |
| 25/09/18 | | | Share |
|
| RVA Reva Medical Presents Key Data Sets at TCT 2018 |
| 24/09/18 | | | Share |
|
| RVA New Data to be Presented at the TCT 2018 Conference |
| 16/08/18 | PRICE SENSITIVE | | Share |
|
| RVA Half Yearly Report and Accounts (Appendix 4D) |
| 08/08/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA Medical Reports Second Quarter 2018 Financial Results |
| 07/08/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA Enters into Amendment to License Agreement with Rutgers |
| 06/08/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Hold Second Quarter 2018 Financial Results Call |
| 01/08/18 | | | Share |
|
| RVA Appendix 4C - quarterly |
| 30/07/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA Enters Peripheral Artery Disease Space with MOTIV |
| 26/07/18 | PRICE SENSITIVE | 53.21KB | Share |
|
| RVA REVA Expands Commercial Access to Fantom in Italy |
| 16/07/18 | PRICE SENSITIVE | 53.95KB | Share |
|
| RVA Appendix 3B |
| 06/07/18 | | 206.63KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 80.78KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 75.2KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 75.34KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 84.03KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 78.55KB | Share |
|
| RVA Institutional Investor Briefing |
| 27/06/18 | | 2.12MB | Share |
|
| RVA CE Mark Approval of the Full Fantom Encore Product Line |
| 19/06/18 | PRICE SENSITIVE | 53.05KB | Share |
|
| RVA Change of Director's Interest Notice |
| 18/06/18 | | 81.12KB | Share |
|
| RVA Change of Director's Interest Notice |
| 04/06/18 | | 81.14KB | Share |
|
| RVA REVA Announces Positive 24-Month Clinical Results |
| 24/05/18 | PRICE SENSITIVE | 60.9KB | Share |
|
| RVA REVA Symposium Showcases Clinical Data |
| 24/05/18 | PRICE SENSITIVE | 5.43MB | Share |
|
| RVA Appendix 3B |
| 21/05/18 | | | Share |
|
| RVA Final Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | | Share |
|
| RVA Results of Annual General Meeting |
| 17/05/18 | | | Share |
|
| RVA Annual General Meeting Presentation |
| 17/05/18 | | | Share |
|
| RVA REVA Announces First Implant of Fantom in Turkey |
| 16/05/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Hold Annual General Meeting of Stockholders |
| 10/05/18 | | | Share |
|
| RVA Q1 2018 Quarterly Report on Form 10-Q |
| 10/05/18 | | | Share |
|
| RVA REVA Medical Reports First Quarter 2018 Financial Results |
| 09/05/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Hold First Quarter 2018 Financial Results Call |
| 02/05/18 | | | Share |
|
| RVA Appendix 4C - quarterly |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Present Full Two-Year Fantom II Data at EuroPCR |
| 17/04/18 | | | Share |
|
| RVA Notice of Meeting and Proxy Statement for 2018 AGM |
| 06/04/18 | | | Share |
|
| RVA REVA Initiates Commercial Distribution Partnership in Turkey |
| 03/04/18 | PRICE SENSITIVE | | Share |
|
| RVA Change of Directors Interest Notice |
| 03/04/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 29/03/18 | | | Share |
|
| RVA Appendix 4G |
| 29/03/18 | | | Share |
|
| RVA REVA Announces First Implant of Fantom Encore in Switzerland |
| 28/03/18 | PRICE SENSITIVE | | Share |
|
| RVA Board Member Not Standing for Re-Election |
| 27/03/18 | | | Share |
|
| RVA Institutional Investor Briefing |
| 14/03/18 | | | Share |
|
| RVA Appendix 3B |
| 09/03/18 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 09/03/18 | | | Share |
|
| RVA Form S-8 Filed with the SEC |
| 08/03/18 | | | Share |
|
| RVA Annual Report on Form 10-K |
| 08/03/18 | | | Share |
|
| RVA REVA Reports 2017 Financial Results |
| 08/03/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Present at Cowen 38th Annual Health Care Conference |
| 07/03/18 | | | Share |
|
| RVA REVA to hold Financial Results Call |
| 01/03/18 | | | Share |
|
| RVA Preliminary Final Report |
| 28/02/18 | PRICE SENSITIVE | | Share |
|
| RVA REVA Announces CE Mark and First Implant of Fantom Encore |
| 26/02/18 | PRICE SENSITIVE | | Share |
|
| RVA Initial Director's Interest Notice |
| 06/02/18 | | | Share |
|
| RVA Director Appointment |
| 05/02/18 | | | Share |
|
| RVA Appendix 4C - Quarterly |
| 01/02/18 | PRICE SENSITIVE | | Share |
|
| RVA First Implant of the Fantom Bioresorbable Scaffold in Italy |
| 25/01/18 | PRICE SENSITIVE | | Share |
|
| RVA Notification of Distribution of Substantial Holder Shares |
| 11/01/18 | | | Share |
|
| RVA Institutional Investor Briefing |
| 08/01/18 | | | Share |
|
| RVA REVA to present at Piper Jaffray Healthcare Conference |
| 28/11/17 | | | Share |
|
| RVA Appendix 3B |
| 10/11/17 | | | Share |
|
| RVA REVA Medical reports Third Quarter 2017 Financial Results |
| 08/11/17 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Present at Canaccord Genuity Forum |
| 02/11/17 | | | Share |
|
| RVA REVA to Hold Third Quarter 2017 Financial Results Call |
| 01/11/17 | | | Share |
|
| RVA New Fantom Data Demonstrates Safety at 2 Years |
| 01/11/17 | PRICE SENSITIVE | | Share |
|
| RVA Appendix 4C - quarterly |
| 31/10/17 | PRICE SENSITIVE | | Share |
|
| RVA REVA to Present Fantom 24-Month Data at TCT 2017 |
| 24/10/17 | | | Share |
|
| RVA Launch of Fantom in Switzerland |
| 16/10/17 | PRICE SENSITIVE | | Share |
|
| RVA Institutional Investor Briefing |
| 11/10/17 | | | Share |
|
| RVA Director Appointment/Resignation |
| 20/09/17 | | | Share |
|
| RVA Company Secretary Appointment/Resignation |
| 01/09/17 | | | Share |
|
| RVA Change of Director's Interest Notice |
| 31/08/17 | | | Share |
|
| RVA Appendix 3B |
| 29/08/17 | | | Share |
|
